415 related articles for article (PubMed ID: 30912953)
1. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
[TBL] [Abstract][Full Text] [Related]
5. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
Zeng L; Ma W; Shi L; Chen X; Wu R; Zhang Y; Chen H; Chen H
Int J Nanomedicine; 2019; 14():6357-6369. PubMed ID: 31496691
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
Jin J; Zhou KK; Park K; Hu Y; Xu X; Zheng Z; Tyagi P; Kompella UB; Ma JX
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6230-7. PubMed ID: 21357401
[TBL] [Abstract][Full Text] [Related]
7. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.
Park K; Chen Y; Hu Y; Mayo AS; Kompella UB; Longeras R; Ma JX
Diabetes; 2009 Aug; 58(8):1902-13. PubMed ID: 19491211
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization.
Huang L; Liang W; Zhou K; Wassel RA; Ridge ZD; Ma JX; Wang B
Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943243
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
11. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
12. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways.
Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
[TBL] [Abstract][Full Text] [Related]
15. JP1, a polypeptide specifically targeting integrin αVβ3, ameliorates choroidal neovascularization and diabetic retinopathy in mice.
Xie Z; Wu XJ; Cheng RW; Cui JH; Yuan ST; Zhou JW; Liu QH
Acta Pharmacol Sin; 2023 Apr; 44(4):897-912. PubMed ID: 36280689
[TBL] [Abstract][Full Text] [Related]
16. Expression, distribution and function of kinin B
Hachana S; Bhat M; Sénécal J; Huppé-Gourgues F; Couture R; Vaucher E
Br J Pharmacol; 2018 Mar; 175(6):968-983. PubMed ID: 29285756
[TBL] [Abstract][Full Text] [Related]
17. The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders.
Hu TT; Vanhove M; Porcu M; Van Hove I; Van Bergen T; Jonckx B; Barbeaux P; Vermassen E; Feyen JHM
Exp Eye Res; 2019 Mar; 180():43-52. PubMed ID: 30472075
[TBL] [Abstract][Full Text] [Related]
18. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
[TBL] [Abstract][Full Text] [Related]
19. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
[TBL] [Abstract][Full Text] [Related]
20. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]